Thermo Fisher Scientific has invested US $ 59 million for the expansion of its laboratory operations in Highland Heights, Kentucky, USA.
With this expansion, Thermo Fischer will be able to deliver life-changing medicines to patients.
The current facility, at 71,600-sq-ft, will grow to 114,000-sq-ft and be completed in stages by the end of 2024.
The company anticipates it will add 200 new jobs for people working in the facility over the next five years.
The expansion will add to the clinical research business’s sample management and testing capacity, supporting new therapeutics such as vaccines and cell and gene therapy products.
The central lab also offers safety testing including automated chemistry, urinalysis and hematology, anatomic pathology, flow cytometry, microbiology, and molecular assays.
It also provides clinical sample management, processing, and storage; kit design and preparation for the collection of clinical samples; and sample testing services.
A biomarker lab offers support for regulated biomarkers with immunoassays, flow cytometry, and molecular assays.
|Thermo Fisher Scientific